Table 4.
Standardised prevalence of chronic diseases in patients with COPD
| EDC |
Observed prevalence |
Expected prevalence |
SPR* | Lower CI | Upper CI |
|---|---|---|---|---|---|
| % COPD | % COPD | ||||
|
Congestive heart failure |
8.03 |
3.34 |
2.41 |
1.88 |
2.93 |
|
Chronic liver disease |
4.99 |
2.63 |
1.89 |
1.37 |
2.42 |
|
Asthma |
5.83 |
3.36 |
1.73 |
1.29 |
2.18 |
|
Generalised atherosclerosis |
10.47 |
6.25 |
1.67 |
1.35 |
1.99 |
|
Osteoporosis |
6.98 |
4.91 |
1.42 |
1.09 |
1.75 |
|
Ischaemic heart disease |
8.45 |
6.00 |
1.41 |
1.11 |
1.71 |
|
Schizophrenia |
1.15 |
0.85 |
1.35 |
0.57 |
2.12 |
|
Thyroid disease |
14.21 |
11.06 |
1.28 |
1.07 |
1.50 |
|
Chronic renal failure |
6.34 |
4.96 |
1.28 |
0.96 |
1.59 |
|
Anxiety/Depression |
20.20 |
15.86 |
1.27 |
1.10 |
1.45 |
|
Cardiac valve disease |
2.21 |
1.76 |
1.25 |
0.73 |
1.77 |
|
Cardiac arrhythmia |
15.81 |
12.70 |
1.25 |
1.05 |
1.44 |
|
Obesity |
25.32 |
20.49 |
1.24 |
1.08 |
1.39 |
|
Chronic skin ulcer |
2.37 |
1.96 |
1.20 |
0.72 |
1.69 |
|
Glaucoma |
5.31 |
4.51 |
1.18 |
0.86 |
1.46 |
|
Cerebrovascular disease |
7.49 |
6.48 |
1.16 |
0.89 |
1.42 |
|
Diabetes mellitus |
20.77 |
18.24 |
1.14 |
0.98 |
1.29 |
|
Degenerative joint disease |
5.67 |
5.11 |
1.11 |
0.82 |
1.40 |
|
Malignant neoplasms |
12.90 |
11.63 |
1.11 |
0.92 |
1.30 |
|
Disorders of lipid metabolism |
34.44 |
31.32 |
1.10 |
0.98 |
1.22 |
|
Arterial hypertension |
51.98 |
48.14 |
1.08 |
0.99 |
1.17 |
|
Deafness, hearing loss |
8.19 |
7.87 |
1.04 |
0.82 |
1.27 |
|
Parkinson’s disease |
1.66 |
1.71 |
0.97 |
0.50 |
1.44 |
|
Benign prostatic hypertrophy |
15.81 |
16.41 |
0.96 |
0.81 |
1.11 |
| Dementias | 1.92 | 2.56 | 0.75 | 0.41 | 1.08 |
EDC: expanded diagnosis cluster.
(*) Standardised prevalence ratio.